Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive and Neural Mechanisms of Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder Part II: Mediation Effects

NCT07641205 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07641205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07641205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive and Neural Mechanisms of Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder Part II: Mediation Effects
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2027
Completion date
October 31, 2029
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avoidant/restrictive food intake disorder (arfid)